Whitehawk Therapeutics Inc

NASDAQ:WHWK

Biotechnology

Healthcare
$3.13 +1.42%

+$0.06 today

Market cap
$184.70M
Beta
0.77
P/E (TTM)
-2.6
EPS (TTM)
-$1.67
52W Low $1.57High $5.50

Volume 0.28M

Average 0.31M

WHWK Pre-Tax Margin

Income before tax as a percentage of revenue.

Whitehawk Therapeutics IncNASDAQ: WHWK

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin not reported for Q1 FY2026

Over 3 fiscal years it widened by 109.4 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
—— QoQ
Last fiscal yearDec 2025
-288.3%-43.1 pp YoY
LTMMar 2026
—— YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year-43.1 pp——
3 years+109.4 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-288.3%
Year-over-year change
-43.1pp

Pre-Tax Margin vs competitors

How WHWK compares with its peers on the latest reported figures

  • WHWK's FY2025 pre-tax margin of -288.3% is the 2nd highest of the 4 companies compared; the peer median is -339.3%.
  • Its year-over-year change of -43.1 pp is the 3rd highest of 4, against a peer median of -9.2 pp.
  • Over three fiscal years its change of +109.4 pp compares with a peer median of +29.5 pp.
WHWK Competitors Peer median
Pre-Tax Margin for WHWK and competitors
Company Period LTM level YoY 3-year change
MGNXMacroGenics, Inc.LTM Mar 2026-45.2% -9.2 pp+29.5 pp
WHWKWhitehawk Therapeutics IncFY2025-288.3% -43.1 pp+109.4 pp
OVIDOvid Therapeutics Inc.LTM Mar 2026-339.3% +4217.8 pp+3364.5 pp
CLNNClene Inc.LTM Mar 2026-25009.7% -16703.7 pp-6761.3 pp
IMMXImmix Biopharma, Inc.FY2025— ——
ZNTLZentalis Pharmaceuticals, Inc.FY2025— ——
PLRXPliant Therapeutics, Inc.FY2025— ——
ONCYOncolytics Biotech Inc.FY2025— ——
CNTXContext Therapeutics Inc.FY2025— ——
Peer median (excluding WHWK) -339.3%-9.2 pp+29.5 pp

Competitors are the stored peer set for WHWK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.12M15.22M24.35M25.98M7.15M
Cost of Revenue19.67M34M51.74M54.05M760K
Gross Profit(18.55M)(18.78M)(27.38M)(28.07M)6.39M
Gross Margin-1656.3%-123.4%-112.4%-108.0%89.4%
Research & Development19.67M32.66M48.93M51.03M90.96M
Selling, General & Admin18.51M40.18M44.55M36.75M29.82M
Operating Expenses92.67M43.9M44.55M39.39M120.79M
Depreciation & Amortization105K159K169K193K79K
EBITDA(36.96M)(58.8M)(65.37M)(64.63M)(20.52M)
EBITDA Margin-3299.6%-386.4%-268.4%-248.7%-287.2%
Operating Income(111.22M)(62.68M)(71.93M)(67.46M)(114.4M)
Operating Margin-9930.1%-411.9%-295.4%-259.6%-1601.1%
Interest Income13K2.4M6.4M3.93M6.23M
Interest Expense665K230K231K154K0
Other Income / Expenses1.13M2.17M6.17M3.77M93.8M
Income Before Tax(110.09M)(60.51M)(65.77M)(63.69M)(20.6M)
Pre-Tax Margin-9829.3%-397.7%-270.0%-245.1%-288.3%
Income Tax Expense2K0000
Net Income(110.09M)(60.51M)(65.77M)(63.69M)(20.6M)
Net Margin-9829.5%-397.7%-270.0%-245.1%-288.3%
EPS (Basic)(12.41)(2.69)(2.44)(2.36)(0.33)
EPS (Diluted)(12.41)(2.69)(2.44)(2.36)(0.33)
Weighted Avg Shares8.87M22.51M26.92M27.03M61.89M
Weighted Avg Shares (Diluted)8.92M22.51M26.92M27.03M61.89M

Whitehawk Therapeutics Inc

NASDAQ:WHWK

Intrinsic Alpha fair value

Locked

Current Price

$3.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.